Paul Dunman, Ph.D.
Phone: (585) 276-5700
Antimicrobial drug discovery using pathogenic Staphylococcus aureus and Acinetobacter baumannii: exploiting components of the bacterial RNA metabolism machinery; characterizing prokaryotic ribonucleases; understanding the impact of the host environment on antibiotic resistance and virulence factor expression.
Katherine Ebsworth-Mojica, M.D.
Developing the Adenylate Kinase assay for use with Mycobacterium tuberculosis and identifying antitubercular drugs.